To switch to alemtuzumab or cladribine you would need to have had a relapse and new lesions on your MRI. You would not be eligible for AHSCT as DMF is not classified as a high-efficacy DMT.
0 subscriptions will be displayed on your profile (edit)
Skip for now
For your security, we need to re-authenticate you.
Click the link we sent to , or click here to sign in.